These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 13130125)
1. The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609. Perry RJ; Ridgway ND J Lipid Res; 2004 Jan; 45(1):164-73. PubMed ID: 13130125 [TBL] [Abstract][Full Text] [Related]
3. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? Luberto C; Hannun YA J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970 [TBL] [Abstract][Full Text] [Related]
4. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells. Larsen EC; Hatcher JF; Adibhatla RM Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680 [TBL] [Abstract][Full Text] [Related]
5. Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. Fukasawa M; Nishijima M; Hanada K J Cell Biol; 1999 Feb; 144(4):673-85. PubMed ID: 10037789 [TBL] [Abstract][Full Text] [Related]
6. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Meng A; Luberto C; Meier P; Bai A; Yang X; Hannun YA; Zhou D Exp Cell Res; 2004 Jan; 292(2):385-92. PubMed ID: 14697345 [TBL] [Abstract][Full Text] [Related]
7. The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytes. Milhas D; Andrieu-Abadie N; Levade T; Benoist H; Ségui B Int J Mol Sci; 2012; 13(7):8834-8852. PubMed ID: 22942738 [TBL] [Abstract][Full Text] [Related]
8. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis. Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner. Ito J; Nagayasu Y; Ueno S; Yokoyama S J Biol Chem; 2002 Nov; 277(47):44709-14. PubMed ID: 12228236 [TBL] [Abstract][Full Text] [Related]
10. Role of sphingolipids in the transport of prosaposin to the lysosomes. Lefrancois S; Michaud L; Potier M; Igdoura S; Morales CR J Lipid Res; 1999 Sep; 40(9):1593-603. PubMed ID: 10484606 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin. Dai Q; Liu J; Chen J; Durrant D; McIntyre TM; Lee RM Oncogene; 2004 Apr; 23(20):3650-8. PubMed ID: 15077187 [TBL] [Abstract][Full Text] [Related]
12. Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall. Li W; Yang X; Xing S; Bian F; Yao W; Bai X; Zheng T; Wu G; Jin S Oxid Med Cell Longev; 2014; 2014():823071. PubMed ID: 24817993 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. Luberto C; Yoo DS; Suidan HS; Bartoli GM; Hannun YA J Biol Chem; 2000 May; 275(19):14760-6. PubMed ID: 10799564 [TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor-induced proliferation of primary astrocytes. evidence for the involvement of sphingomyelin biosynthesis. Riboni L; Viani P; Bassi R; Giussani P; Tettamanti G J Biol Chem; 2001 Apr; 276(16):12797-804. PubMed ID: 11278937 [TBL] [Abstract][Full Text] [Related]
16. Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide. Gulbins A; Schumacher F; Becker KA; Wilker B; Soddemann M; Boldrin F; Müller CP; Edwards MJ; Goodman M; Caldwell CC; Kleuser B; Kornhuber J; Szabo I; Gulbins E Mol Psychiatry; 2018 Dec; 23(12):2324-2346. PubMed ID: 30038230 [TBL] [Abstract][Full Text] [Related]
17. Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications. Bhat AH; Dar KB; Khan A; Alshahrani S; Alshehri SM; Ghoneim MM; Alam P; Shakeel F Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328726 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479 [TBL] [Abstract][Full Text] [Related]
19. Prodrug modification increases potassium tricyclo[5.2.1.0(2,6)]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells. Bai A; Meier GP; Wang Y; Luberto C; Hannun YA; Zhou D J Pharmacol Exp Ther; 2004 Jun; 309(3):1051-9. PubMed ID: 14960662 [TBL] [Abstract][Full Text] [Related]
20. A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. Yasuda S; Kitagawa H; Ueno M; Ishitani H; Fukasawa M; Nishijima M; Kobayashi S; Hanada K J Biol Chem; 2001 Nov; 276(47):43994-4002. PubMed ID: 11546801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]